INTUITIVE SURGICAL INC
ISRGNASDAQ🏆 #96 by market capEarnings Oct 20US Equity
$401.23▲ $8.02 (+2.00%)
Market closed · at close1h—
24h▲ 2.0%
7d▲ 6.9%
14d▲ 13.6%
30d▼ 1.4%
1y▼ 16.1%
🏦Market Cap
$141.75B
Mid Cap
📈Revenue Growth (YoY)
+20.7%
Healthy
📊Gross Margin
66.7%
High
💵FCF Margin
29.2%
Strong
⚖️P/S Ratio
12.3x
Elevated
Otter Score
56
Weak
📊
Analyst Ratings
Price
$401.23
Total
57
Raised
14
Lowered
8
Avg PT
$490.84
| Institution | Action | Rating | Date |
|---|---|---|---|
HSBC | Downgraded | Buy → Hold | 2026-07-30 |
RBC Capital | Reiterated | Outperform | 2026-07-17 |
Stifel | Reiterated | Buy | 2026-07-17 |
BTIG | Reiterated | Buy | 2026-07-17 |
Baird | Reiterated | Outperform | 2026-07-17 |
Leerink Partners | Reiterated | Outperform | 2026-07-17 |
Bernstein | Reiterated | Outperform | 2026-07-17 |
Citigroup | Reiterated | Buy | 2026-07-17 |
Raymond James | Reiterated | Outperform | 2026-07-17 |
Piper Sandler | Reiterated | Overweight | 2026-07-17 |
JP Morgan | Reiterated | Overweight | 2026-07-17 |
Mizuho | Reiterated | Neutral | 2026-07-17 |
Wells Fargo | Reiterated | Overweight | 2026-07-17 |
TD Cowen | Reiterated | Buy | 2026-07-17 |
Evercore ISI Group | Reiterated | In Line | 2026-07-17 |
Truist Securities | Reiterated | Buy | 2026-07-16 |
B of A Securities | Reiterated | Buy | 2026-05-18 |
Barclays | Reiterated | Overweight | 2026-04-23 |
Goldman Sachs | Reiterated | Buy | 2026-04-09 |
UBS | Reiterated | Neutral | 2026-03-17 |
Freedom Capital Markets | Upgraded | Hold → Buy | 2026-01-27 |
Freedom Broker | Upgraded | Hold → Buy | 2026-01-26 |
Deutsche Bank | Downgraded | Hold → Sell | 2025-06-09 |
Morgan Stanley | Upgraded | Equal Weight → Overweight | 2024-12-02 |
Erste Group | Upgraded | Hold → Buy | 2024-11-19 |
Redburn Atlantic | Upgraded | Neutral → Buy | 2024-08-02 |
Jefferies | Reiterated | Hold | 2024-04-19 |
William Blair | Reiterated | Outperform | 2023-03-23 |
Argus Research | Reiterated | Buy | 2022-12-22 |
Wolfe Research | Reiterated | Peer Perform → Perform | 2022-04-06 |
Redburn Partners | Downgraded | Buy → Neutral | 2022-01-25 |
SVB Leerink | Reiterated | Market Perform | 2021-08-26 |
Oppenheimer | Upgraded | Underperform → Perform | 2021-04-21 |
Canaccord Genuity | Reiterated | Buy | 2020-07-22 |
Cantor Fitzgerald | Reiterated | Overweight | 2020-01-10 |
First Shanghai | Reiterated | Buy | 2019-11-29 |
PiperJaffray | Upgraded | Neutral → Overweight | 2018-10-10 |
Stifel Nicolaus | Reiterated | Buy | 2018-07-20 |
Bank of America | Reiterated | Buy | 2018-07-17 |
BTIG Research | Downgraded | Buy → Neutral | 2016-04-01 |
Northland Securities | Upgraded | Underperform → Market Perform | 2014-10-22 |
Northland Capital Markets | Upgraded | Underperform → Market Perform | 2014-10-22 |
Leerink Swann | Upgraded | Market Perform → Outperform | 2014-10-17 |
Sterne Agee | Upgraded | Underperform → Neutral | 2014-04-29 |
SunTrust Robinson Humphrey | Reiterated | Buy | 2014-04-23 |
JMP Securities | Upgraded | Market Underperform → Market Outperform | 2014-04-02 |
ISI Group | Downgraded | Strong Buy → Buy | 2014-01-21 |
CRT Capital | Reiterated | Sell | 2013-11-26 |
Northland | Downgraded | Market Perform → Underperform | 2013-10-18 |
First Analysis | Downgraded | Equal Weight → Underweight | 2013-09-03 |
Ameriprise Financial | Downgraded | Buy → Sell | 2013-07-09 |
Wedbush | Reiterated | Outperform | 2013-06-18 |
Janney Capital | Reiterated | Buy | 2013-01-18 |
Lazard | Upgraded | Neutral → Buy | 2013-01-14 |
Barrington Research | Upgraded | Market Perform → Outperform | 2012-10-31 |
Dougherty & Co. | Reiterated | Buy | 2012-04-18 |
Dougherty | Reiterated | Buy | 2012-04-18 |
One row per institution, most recent rating